Table 5.

Quality of life scores^* based on SF-36 of both intervention periods after treatment with transdermal fentanyl or sustained release oral morphine. Values are means (95% confidence intervals)

Category	Fentanyl	Morphine	P value
Physical functioning
Physical functioning	35.4 (32.2 to 38.7)	34.9 (31.7 to 38.2)	0.712
Role physical	20.3 (15.8 to 24.8)	15.1 (11.3 to 18.9)	0.100
Bodily pain	32.5 (30.1 to 34.9)	27.8 (25.5 to 30.1)	<0.001
General health	42.5 (39.6 to 54.4)	40.7 (37.8 to 43.5)	0.246
Summary measurement	28.6 (27.5 to 29.7)	27.4 (26.3 to 28.5)	0.004
Mental health
Vitality	38.0 (35.4 to 40.6)	34.6 (31.7 to 37.3)	<0.001
Social functioning	47.1 (43.6 to 50.5)	44.0 (40.5 to 47.5)	0.002
Role emotional	48.6 (43.6 to 50.5)	44.8 (38.8 to 50.8)	0.458
Mental health	61.5 (58.8 to 64.2)	59.1 (56.3 to 61.8)	0.020
Summary measurement	44.4 (42.8 to 46.0)	43.1 (41.5 to 44.8)	0.030

^*From 0 (worst possible) to 100 (best possible).